Table 1.
Mice | % Δ(pO2) | % Δ(iqr) |
0.5-mm capsules | ||
Healthy mice | ||
Mouse 1 | −15.8 | 51.2 |
Mouse 2 | −28.2 | −26.7 |
Mouse 3 | −26.5 | −29.8 |
Mouse 4 | −42.0 | −40.8 |
Mouse 5 | −34.4 | −26.3 |
Diabetic mice | ||
Mouse 1 | −4.7 | 30.6 |
Mouse 2 | −14.7 | −38.1 |
Mouse 3 | −15.7 | −47.3 |
Mouse 4 | −19.2 | −52.1 |
Mouse 5 | −22.6 | −48.9 |
1.5-mm capsules | ||
Healthy mice | ||
Mouse 1 | −2.5 | 187.1 |
Mouse 2 | 12.3 | 27.4 |
Mouse 3 | −14.1 | −21.3 |
Mouse 4 | 9.4 | 6.2 |
Mouse 5 | −0.6 | −29.2 |
Diabetic mice | ||
Mouse 1 | −1.2 | 156.2 |
Mouse 2 | 6.5 | 5.1 |
Mouse 3 | 0.4 | 10.2 |
Mouse 4 | −0.9 | −13.1 |
Mouse 5 | 0.4 | 29.9 |
Each row corresponds to an individual mouse from each of the four groups studied. For 0.5-mm capsules, decrease in pO2 over time is accompanied by decrease in capsule dispersity for both islet-containing (diabetic mice) and empty (healthy mice) capsules, with the exception of one healthy mouse. For 1.5-mm capsules, no consistent trend across each animal group can be observed. pO2 and iqr values are calculated over 12 image slices for each mouse. Each MRI measurement is the average of two acquisitions.